- Home
- IZM vs GOVX Comparison
IZM vs GOVX Comparison
Compare IZM & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- GOVX
- Stock Information
- Founded
- IZM 2011
- GOVX 2001
- Country
- IZM China
- GOVX United States
- Employees
- IZM N/A
- GOVX N/A
- Industry
- IZM Consumer Electronics/Video Chains
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- GOVX Health Care
- Exchange
- IZM Nasdaq
- GOVX Nasdaq
- Market Cap
- IZM 23.7M
- GOVX 23.8M
- IPO Year
- IZM 2023
- GOVX N/A
- Fundamental
- Price
- IZM $1.74
- GOVX $2.64
- Analyst Decision
- IZM
- GOVX Strong Buy
- Analyst Count
- IZM 0
- GOVX 5
- Target Price
- IZM N/A
- GOVX $14.20
- AVG Volume (30 Days)
- IZM 64.9K
- GOVX 772.9K
- Earning Date
- IZM 01-14-2025
- GOVX 02-27-2025
- Dividend Yield
- IZM N/A
- GOVX N/A
- EPS Growth
- IZM N/A
- GOVX N/A
- EPS
- IZM N/A
- GOVX N/A
- Revenue
- IZM $177,933,890.00
- GOVX $3,090,161.00
- Revenue This Year
- IZM N/A
- GOVX N/A
- Revenue Next Year
- IZM N/A
- GOVX $150.51
- P/E Ratio
- IZM N/A
- GOVX N/A
- Revenue Growth
- IZM N/A
- GOVX N/A
- 52 Week Low
- IZM $1.61
- GOVX $1.09
- 52 Week High
- IZM $52.21
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- IZM 28.08
- GOVX 58.87
- Support Level
- IZM $1.61
- GOVX $2.39
- Resistance Level
- IZM $1.90
- GOVX $2.75
- Average True Range (ATR)
- IZM 0.12
- GOVX 0.18
- MACD
- IZM -0.04
- GOVX 0.03
- Stochastic Oscillator
- IZM 21.31
- GOVX 82.26
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.